共 10 条
[1]
GUT[P]. TANI MASUYUKI.日本专利:JPH05161726A,1993-06-29
[2]
Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. Abad E,Tural C,Mirapeix E,et al. Journal of Autoimmunity . 1997
[3]
Antineutrophil cytoplasmic antibodies in ulcerative colitis.Comparsion with other colitides/diarrhoeal illness. Duerr RH,Targan SR,Landers CJ,et al. Gastroenterology . 1991
[4]
Antibodies to cathepsin G in Crohn′s disease. Mayet WJ,Hermann E,Finsterwalder J,et al. European Journal of Clinical Investigation . 1992
[5]
Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: characterization and clinical correlates. Mulder AHL,Broekroelofs J,Horst G,et al. Clinical and Experimental Immunology . 1994
[6]
Prospective evaluation of antineutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease. Freeman H,Roeck B,Devine D,et al. Canadian Journal of Gastroenterology . 1997
[7]
Anti-neutrophil cytoplasmic antibodies(ANCA) directed against bactericidal/permeability increasing protein( BPI): a new seromarker for inflammatory bowel disease and associated disorders. Stoffel MP,Csernok E,Herzberg C,et al. Clinical and Experimental Immunology . 1996
[8]
Diagnosis and management of ulcerative colitis. Tabaqchahi S,Jumaa P. British Medical Journal . 1995
[9]
The value of indirect immunofluorescence and solid phase techniques for ANCA detection: a report on the first phase of an international cooperative study on the standardization of ANCA assays. Hagen EC,Andrassy K,Csernok E,et al. Journal of Immunological Methods . 1993
[10]
Immunodiagnostic and pathophysiological aspects of antineutrophil cytoplasmic autoantibodies in vasculitis. Gross WL,Csernok E. Current Opinion in Rheumatology . 1995